Introduction
============

Membrane transport proteins can be divided into four types: ion channels; transporters; aquaporins; and ATP-powered pumps <http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=mcb.figgrp.4031>. Genes from all four categories are ancient \-- with members present in most, if not all, prokaryotes, as well as in virtually all cell types of all eukaryotes. Transporters in eukaryotic cells move ions, sugars, amino acids and other molecules across all cellular and organelle membranes (cell surface, mitochondrial, endoplasmic reticulum, Golgi apparatus and other vesicles) \-- with the possible exception of nuclear membranes (which have pores). The portion of the cell exposed to the lumen is called the apical surface; the rest of the cell (ie sides and base) makes up the basolateral surface. Movement of ions or other molecules into the cell is called influx; movement of ions or other molecules out of the cell is termed efflux.

Membrane transport proteins can be either passive or active. Passive transporters (also called uni-porters or facilitative transporters) transport substrates down a concentration gradient. By contrast, active transporters (or cotransporters) couple the movement of one type of ion or molecule against its concentration gradient, to the movement of another ion or molecule down its concentration gradient. Like ATP pumps, cotransporters mediate coupled reactions in which an energetically unfavourable reaction is coupled to an energetically favourable reaction. When the transported molecule and cotransported ion move in the same direction across a membrane, the transporter is called a symporter; when they move in opposite directions, the transporter is called an antiporter (or exchanger). If the intracellular net charge following transport becomes more negative, the process is termed electronegative; if the intracellular net charge becomes more positive, the process is called electropositive; if the resulting intracellular net charge remains unchanged, the process is termed electroneutral.

Ion channels are pore-forming membrane proteins that help to establish and maintain small-voltage gradients across plasma membrane surfaces of all living cells. As such, they regulate the cell\'s electric potential by allowing the flow of ions down their electrochemical gradient. Ion channels usually occur in the closed state. Cationic and anionic substrates are transferred down their electrochemical gradients at extremely high efficiencies (as much as 10^8^sec^-1^). More than 400 genes are known to encode ion channel subunits \[[@B1]\].

Transporters facilitate the movement of a specific substrate \-- either with or against its concentration gradient \-- and the conformational change in the transporter protein is important in this transfer process. Transporters move molecules at only about 10^2^-10^4^sec^-1^, a rate much slower than that associated with channel proteins. Many of these transporters belong to the solute-carrier *(SLC)*gene superfamily, and include passive transporters, sym-porters and antiporters, as well as mitochondrial and vesicular transporters. The *SLC*superfamily comprises 55 gene families, having at least 362 putatively functional protein-coding genes \[[@B2]\].

Aquaporins are a unique class of transporter. These proteins are bi-directional membrane channels which transport water, but they are not ion channels because the H~2~O is transported as an uncharged molecule and not as an ion. The driving force for aquaporins is the presence of osmotic gradients across membranes \[[@B3]\]. There are 13 putatively functional *AQP*genes in the human genome <http://www.genenames.org/>.

ATP-powered pumps include the ATP-binding cassette (ABC) pumps. These pumps use energy released by ATP hydrolysis to move substrates across membranes in or out of cells or into cellular vesicles, against their electrochemical gradient. ABC pumps constitute a large, diverse and ubiquitous superfamily. Most *ABC*genes encode membrane-bound proteins that participate directly in the transport of a wide range of molecules across membranes \[[@B4]\]. ABC transporters can broadly be categorised as importers or exporters, depending on the direction of transport relative to the cytoplasm \[[@B5]\]. Plants carry a particularly large complement of ABC proteins; these pumps are associated with the need to establish steep concentration gradients of solutes across cellular membranes, as well as metabolic versatility. Plant ABC pumps are not only involved in the transport of hormones, lipids, secondary metabolites, metals and xenobiotics \[[@B4]\], but also contribute to osmolality and ion channel and phytoalexin functions (plant-pathogen interactions). Even the evolution of seed size in the tomato has been associated with an *ABC*transporter gene \[[@B6]\].

Details of the ABC proteins
===========================

By definition, ABC proteins possess an ATP binding cassette, also known as the \'nucleotide-binding domain\' (NBD). The NBD contains several highly conserved motifs, including the Walker A and Walker B sequences, the ABC signature motif, the H loop and the Q loop. ABC transporters also contain trans-membrane domains (TMDs), each of which comprises several hydrophobic *α*-helices. The ABC transporter core unit consists of four domains, two NBDs and two TMDs. The two NBDs together bind and hydrolyse ATP (thereby providing the driving force for transport), while the TMDs participate in substrate recognition and translocation across the lipid membrane \[[@B4]\]. Some *ABC*genes encode proteins that are \'half-transporters\' (meaning that two subunits bind as homodimers or a heterodimer), whereas others are \'full-transporters\'.

The human *ABC*gene family
==========================

The human genome carries 49 ABC genes, arranged in seven subfamilies, designated A to G (Figure [1](#F1){ref-type="fig"} and Table [1](#T1){ref-type="table"}). This diverse transporter family has members that play pivotal roles in many cellular processes. For example, ABC transporters are responsible for the multidrug resistance of cancer cells \[[@B7]\]. ABC proteins also transport a number of substrates, including metal ions, peptides, amino acids, sugars and a large number of hydrophobic compounds and metabolites across the plasma membrane, and also intracellular membranes. The function of each *ABC*gene product, when known, is listed in the far right column of Table [2](#T2){ref-type="table"}. At the present time, 21 *ABC*pseudogenes have been identified \[[@B8]\] and localised to chromosomal regions (Table [3](#T3){ref-type="table"}).

![**Clustering dendrogram of the human ATP-binding cassette *(ABC)*transporter genes**. The root *\'ABC\'*is omitted from the figure to simplify it. Thus, the correct gene name for \'Bl\' is *ABCBI*, for \'B4\' is *ABCB4*, and so forth.](1479-7364-3-3-281-1){#F1}

###### 

Human *ABC*gene subfamilies

  Subfamily name   Aliases   Number of genes   Number of pseudogenes
  ---------------- --------- ----------------- -----------------------
  *ABCA*           ABC1      12                5
                                               
  *ABCB*           MDR       11                4
                                               
  *ABCC*           MRP       13                2
                                               
  *ABCD*           ALD       4                 4
                                               
  *ABCE*           OABP      1                 2
                                               
  *ABCF*           GGN20     3                 2
                                               
  *ABCG*           White     5                 2
                                               
  **Total**                  **49**            **21**

###### 

Human *ABC*transporter genes, and their functions, as listed in the HGNC database

  Gene             Chromosome location   Exons   AA     Accession number   Function
  ---------------- --------------------- ------- ------ ------------------ ---------------------------------------------------------------------------------------------------
  *ABCA1*          9q3l.l                36      2261   NM005502           Cholesterol efflux onto HDL
                                                                           
  *ABCA2*          9q34                  27      2436   NM001606           Drug resistance
                                                                           
  *ABCA3*          16pl3.3               26      1704   NM001089           Multidrug resistance
                                                                           
  *ABCA4*          1p22                  38      2273   NM000350           N-retinylidene-phosphatidylethanolamine (PE) efflux
                                                                           
  *ABCA5*          17q24.3               31      1642   NM018672           Urinary diagnostic marker for prostatic intraepithelial neoplasia (PIN)
                                                                           
  *ABCA6*          17q24.3               35      1617   NM080284           Multidrug resistance
                                                                           
  *ABCA7*          19p13.3               31      2146   NM019112           Cholesterol efflux
                                                                           
  *ABCA8*          17q24                 31      1581   NM007168           Transports certain lipophilic drugs
                                                                           
  *ABCA9*          17q24.2               31      1624   NM080283           Might play a role in monocyte differentiation and macrophage lipid homeostasis
                                                                           
                                                                           
                                                                           
  *ABCA10*         l7q24                 27      1543   NM080282           Cholesterol-responsive gene
                                                                           
  *ABCA12*         2q34                  37      2595   NM173076           Has implications for prenatal diagnosis
                                                                           
  *ABCA13*         7p12.3                36      5058   NM152701           Inherited disorder affecting the pancreas
                                                                           
                                                                           
                                                                           
  *ABCB1*          7q21.1                20      1280   NM000927           Multidrug resistance
                                                                           
  *ABCB2 (TAPI)*   6p21.3                11      808    NM000593           Peptide transport
                                                                           
  *ABCB3 (TAP2)*   6p21.3                11      703    NM000544           Peptide transport
                                                                           
  *ABCB4*          7q21.1                25      1279   NM000443           Phosphatidylcholine (PC) transport
                                                                           
  *ABCB5*          7p15.3                17      812    NM178559           Melanogenesis
                                                                           
  *ABCB6*          2q36                  19      842    NM005689           Iron transport
                                                                           
  *ABCB7*          Xq12-q13              14      753    NM004299           Fe/S cluster transport
                                                                           
  *ABCB8*          7q36                  15      718    NM007188           Intracellular peptide trafficking across membranes
                                                                           
  *ABCB9*          12q24                 12      766    NM019625           Located in lysosomes
                                                                           
  *ABCB10*         1q42.13               13      738    NM012089           Export of peptides derived from proteolysis of inner-membrane proteins
                                                                           
  *ABCB11*         2q24                  26      1321   NM003742           Bile salt transport
                                                                           
  *ABCC1*          16p13.1               31      1531   NM004996           Drug resistance
                                                                           
  *ABCC2*          10q24                 26      1545   NM000392           Organic anion efflux
                                                                           
  *ABCC3*          17q22                 19      1527   NM003786           Drug resistance
                                                                           
  *ABCC4*          13q32                 19      1325   NM005845           Nucleoside transport
                                                                           
  *ABCC5*          3q27                  25      1437   NM005688           Nucleoside transport
                                                                           
  *ABCC6*          16p13.1               28      1503   NM001171           Expressed primarily in liver and kidney
                                                                           
  *ABCC7 (CFTR)*   7q31.2                23      1480   NM000492           Chloride ion channel (same as *CFTR*gene in cystic fibrosis)
                                                                           
  *ABCC8*          11p15.1               30      1581   NM000352           Sulfonylurea receptor
                                                                           
  *ABCC9*          12p12.1               32      1549   NM005691           Encodes the regulatory SUR2A subunit of the cardiac K^+^(ATP) channel
                                                                           
  *ABCC10*         6p21.1                19      1464   NM033450           Multidrug resistance
                                                                           
  *ABCC11*         16q12.1               25      1382   NM033151           Drug resistance in breast cancer
                                                                           
  *ABCC12*         16q12.1               25      1359   NM033226           Multidrug resistance
                                                                           
  *ABCC13*         21q11.2               6       325    NM00387            Encodes a polypeptide of unknown function
                                                                           
                                                                           
                                                                           
  *ABCD1*          Xq28                  9       745    NM000033           Very-long-chain fatty acid (VLCFA) transport
                                                                           
  *ABCD2*          12q11-q12             10      740    NM005164           Major modifier locus for clinical diversity in X-linked ALD (X-ALD)
                                                                           
  *ABCD3*          1p22-p21              16      659    NM002858           Involved in import of fatty acids and/or fatty acyl-coenzyme As into the peroxisome
                                                                           
  *ABCD4*          14q24                 19      606    NM005050           May modify the ALD phenotype
                                                                           
  *ABCE1*          4q31                  14      599    NM002940           Oligoadenylate-binding protein
                                                                           
                                                                           
                                                                           
  *ABCF1*          6p21.33               19      845    NM001025091        Susceptibility to autoimmune pancreatitis
                                                                           
  *ABCF2*          7q36                  14      634    NM005692           Tumour suppression at metastatic sites and in endocrine pathway for breast cancer/drug resistance
                                                                           
  *ABCF3*          3q27.1                21      709    NM018358           Also present in promastigotes (one of five forms in the life cycle of trypanosomes)
                                                                           
  *ABCG1*          21q22.3               13      678    NM004915           Cholesterol transport
                                                                           
  *ABCG2*          4q22                  16      655    NM004827           Toxicant efflux, drug resistance
                                                                           
  *ABCG4*          q23.3                 15      646    NM022 69           Found in macrophage, eye, brain and spleen
                                                                           
  *ABCG5*          2p2                   11      65     NM022436           Sterol transport
                                                                           
  *ABCG8*          2p2                   10      673    NM022437           Sterol transport

**Abbreviations**: HGNC, HUGO Gene Nomenclature Committee; AA, number of amino acids; HDL, high density lipoprotein; *CFTR*, cysticfibrosis transmembrane conductance regulator gene; ATP adenosine triphosphate; ALD, adrenoleukodystrophy.

###### 

Human *ABC*transporter pseudogenes (adapted and modified from Piehler *et al*. \[[@B8]\])

  Parental gene   Pseudogene   Chromosomal location   Accession number
  --------------- ------------ ---------------------- ------------------
  *ABCA3*         *ABCA17P*    16p13.3                DQ266102
                                                      
  *ABCA10*        *ABCA10P*    4p16.3                 AK024359
                                                      
  *Abca14\**      *ABCA14P1*   16p12.2                
                                                      
  *Abca15\**      *ABCA15P1*   16p12.2                DR731461
                  *ABCA15P2*   16p12.1                
                                                      
  *ABCB4*         *ABCB4P*     4q32.1                 
                                                      
  *ABCB10*        *ABCB10P1*   15q11.2                
                  *ABCB10P2*   15q13.1                
                  *ABCB10P3*   15q13.1                
                                                      
  *ABCC6*         *ABCC6P1*    16p12.3                DB11925
                  *ABCC6P2*    16p13.11               
                                                      
  *ABCD1*         *ABCD1P1*    2p11.1                 AY344117
                  *ABCDIP2*    10p11.1                
                  *ABCDIP3*    16p11.2                
                  *ABCDIP4*    22q11.1                
                                                      
  *ABCE1*         *ABCE1P1*    Iq31.2                 
                  *ABCEIP2*    7p15.3                 
                                                      
  *ABCF2*         *ABCF2P1*    3p11.2                 
                  *ABCF2P2*    7q11.2                 
                                                      
  *ABCG2*         *ABCG2P1*    14q24.3                
                  *ABCG2P2*    15q23                  

\**Abca14, Abca15*and *Abca16*are mouse genes, with no human orthologues \[[@B9]\]. The mouse genome contains 52 *Abc*genes, whereas the human genome carries 49 *ABC*genes.

Mutations in at least 11 *ABC*genes to date are clearly associated with inherited diseases:\[[@B10]\] Tangier disease T1 (*ABCA1*); Stargardt disease, retinitis pigmentosa and age-related macular degeneration (*ABCA4*); progressive familial intrahepatic cholestasis (*ABCB11*); Dubin-Johnson syndrome (*ABCC2*); pseudoxanthoma elasticum (*ABCC6*); cystic fibrosis (*ABCC7*); X-linked adrenoleukodystrophy (ALD) *(ABCD1*and *ABCD2);*some forms of Zellweger syndrome *(ABCD3*and *ABCD2)*and sitosterolaemia (a rare lipid metabolic disorder inherited as an auto-somal recessive trait) *(ABDG5*and *ABCG8)*. An additional eight *ABC*genes have been implicated in, or are candidates for, other metabolic inherited diseases <http://nutrigene.4t.com:0/humanabc.htm>.

Clans: Comments on sequence identity
====================================

The ABC family is a member of the P-loop-containing nucleoside-triphosphate hydrolase clan (CL0023). The definition of the clan in the Pfam database is: \'A collection of evolutionarily-related Pfam entries. This relationship may be defined by similarity of protein sequence, tertiary structure or profile, as defined by the Hidden Markov model\' \[[@B11],[@B12]\]. At the moment, clan CL0023 contains 55 protein families, including the ABC family.

Subfamily A of the ABC family (*ABCA*)
======================================

Subfamily A contains 12 genes, most of which appear to be involved in lipid trafficking in many diverse organs and cell types. Among the largest of the ABC transporters, some of the ABCA proteins weigh in at more than 2,100 amino acids in length \[[@B10]\]. In fact, the predicted ABCA13 protein contains 5,058 residues, making it the largest ABC protein known. Mutations in specific *ABCA*genes lead to genetic disorders \[[@B13]\], such as Tangier disease T1, familial high-density lipoprotein (HDL) deficiency, Stargardt disease-1, age-related macular degeneration and retinitis pigmentosa (Table [2](#T2){ref-type="table"}).

Subfamily B of the ABC family (*ABCB*)
======================================

This subfamily of 11 genes is unique to mammals; there are four full-transporters and seven half-transporters. Several of the B family members are known to confer multidrug resistance in cancer cells; hence, subfamily B has also been called the \'MDR family of ABC transporters\' \[[@B10]\]. Mutations in *ABCB*genes have been implicated in ankylosing spondylitis, diabetes type 2, coeliac disease, lethal neonatal syndrome, X-linked sideroblastic anaemia with ataxia, and several cholestatic liver diseases of infancy (Table [2](#T2){ref-type="table"}). Many of these genotype-phenotype association studies suggesting the involvement of *ABCB*genes, however, are likely to represent false-positive, inconclusive or under-powered studies, and need further replication in other large cohorts before they can be regarded as \'informative\' and conclusive \[[@B14]\].

Recent genome-wide searches for positive selection in the human genome have suggested the possibility that the metabolism and transport of foreign chemicals (foodstuffs, plant metabolites and drugs) might have undergone natural selection \[[@B15]-[@B17]\]. In this regard, the 230-kilobase (kb) cluster of four cytochrome P450 3A *(CYP3A)*functional genes and two pseudogenes, located at chromosome 7, is only 119 kb distant from the *ABCB1*gene (the transcript of which spans 210 kb). Moreover, the CYP3A enzymes and ABCB1 transporter appear to have very similar substrate profiles, and both are regulated by the pregnane × receptor (PXR) in the liver, intestine, lung and kidney \[[@B18]\]. In addition, positive selection has recently been noted in the ligand-binding domain of PXR \[[@B19]\], lending further credence to the possible co-evolution of these two nearby loci, in response to dietary pressures. Future investigators should look carefully for similar patterns of possible co-evolution by other drug-metabolising genes and drug-transporter genes.

Subfamily C of the ABC family (*ABCC*)
======================================

Subfamily C includes the cystic fibrosis gene *(CFTR*, also called *ABCC7)*plus 12 other genes that encode transporters associated with multidrug resistance. The diverse activities of ABCC transporters include ion-channel and toxin excretion activity and reception on the cell surface; toxin excretion involves various fungal and bacterial toxins \[[@B10]\]. Mutations in one or more of the *ABCC*genes have been implicated in multidrug resistance, Dubin-Johnson syndrome, congenital bilateral aplasia of the vas deferens, diabetes type 2 and paroxysmal kinesigenic choreoathetosis \-- as well as autosomal recessive diseases such as cystic fibrosis, pseudoxanthoma elasticum and hyperinsulinaemic hypoglycaemia of infancy (Table [2](#T2){ref-type="table"}).

The *CFTR*encodes a unique ABC transporter protein. Recent data suggest that CFTR channel activity evolved by converting the conformational changes associated with ATP binding and hydrolysis (found in \'true\' ABC pumps) into an open permeation pathway, by means of intra-protein interactions that stabilise the open state \[[@B20]\]. The \'selective pressure\' in the environment that might have encouraged this unique CFTR protein to evolve to exhibit this characteristic has been suggested to be severe infection \-- that is, cholera epidemics \[[@B21]\].

Subfamily D of the ABC family (*ABCD*)
======================================

Also known as the peroxisomal or ALD transporters, this subfamily contains four genes that encode half-transporters; these subunits form homodimers or heterodimers to make a functional unit. These four human half-transporter genes code for at least 49 distinct proteins by means of 102 alternatively spliced transcripts \[[@B10]\]. Mutations in *ADBD*genes are known to cause ALD and Zellweger syndrome (Table [2](#T2){ref-type="table"}).

Subfamily E of the ABC family (*ABCE*)
======================================

ABCE1 is the single member in this family which is an organic anion-binding protein (its trivial name is OABP), sometimes confused with the 11 *SLCO*genes that encode solute-carrier organic anion transporters \[[@B2]\]. ABCE1 has an ATP-binding domain but lacks the transmembrane domain, making it unlikely that this protein functions as a transporter. Because of 15 alternatively spliced transcripts, the *ABCE1*gene encodes five distinct proteins \[[@B10]\]. ABCE1 has been found to block the activity of ribonuclease L. Activation of ribonuclease L leads to inhibition of protein synthesis in a pivotal pathway involving viral interferon action; hence, ABCE1 functions to promote interferon activity.

Subfamily F of the ABC family (*ABCF*)
======================================

Along with ABCE1, ABCF members also have ATP-binding domains, but no transmembrane domains, making transporter function unlikely. Due to alternatively spliced products, the three *ABCF*genes encode 26 distinct proteins \[[@B10]\]. Because the *ABCF*genes appear to be upregulated by tumour necrosis factor-α, it is believed that members of this subfamily might play a role in inflammatory processes. No diseases have been associated, so far, with either the *ABCE*or *ABCF*genes (Table [2](#T2){ref-type="table"}).

Subfamily G of the ABC family (*ABCG*)
======================================

Subfamily G comprises at least five genes that encode \'reverse half-transporters\', meaning that they form the second half of a heterodimer. Mutations in *ABCG*genes have been implicated in sterol accumulation disorders and atherosclerosis (Table [2](#T2){ref-type="table"}). Due to alternative splicing, at least 18 distinct subunit proteins have been identified as products of the five *ABCG*genes \[[@B10]\]. ABCG1 is involved in cholesterol efflux in macrophages and may regulate cellular lipid homeostasis in other cell types as well. ABCG2 functions in multidrug resistance transport; steroids (cholesterol, oestradiol, progesterone and testosterone) and certain chlorophyll metabolites, as well as organic anions, are transported by ABCG2. ABCG3 is expressed at high levels in the thymus and spleen, suggesting a possible potential role in the transport of specific peptides or hydrophobic compounds from lymphocytes. ABCG5 and ABCG8 both appear to limit intestinal absorption and promote biliary excretion of sterols; their expression is localised primarily in the liver, colon and intestine. Mutations in either of these two genes lead to sitosterolaemia. This is characterised by hyperabsorption plus decreased biliary excretion of dietary sterols, leading to hypercholesterolaemia, tendon and tuberous xanthomata, early-age onset of atherosclerosis, and abnormal blood and liver function test results.

Evolution of the ABC transporter family
=======================================

Clearly, the ancestral *ABC*gene first appeared in unicellular organisms and is therefore ancient, being now present in eubacteria, archaebacteria, plants, fungi, yeast and all animals. The nomenclature of the *ABC*gene family is the same as that developed for more than 150 other gene families and superfamilies in the human and rodent genomes <http://www.genenames.org/>. All of these nomenclature systems followed the original example described for the *CYP*genes. The *CYP*genes were conveniently arranged into families and subfamilies based on percentage amino acid sequence identity \[[@B22]-[@B27]\]. Enzymes that share \~40 per cent or higher identity are assigned to a particular family (designated by an Arabic numeral). Protein sequences sharing \~55 per cent or higher identity are grouped into a particular subfamily (designated by a letter). Enzymes that share greater than \~70 per cent amino acid identity are then named as members within that subfamily (and given Arabic numbers, usually in the sequence in which they were discovered).

For example, sterol 27-hydroxylase and 25-hydroxy-vitamin D~3~1 α-hydroxylase are both assigned to the CYP27 family because they share \>40 per cent sequence identity. Because their protein sequences are \< 55 per cent identical, however, sterol 27-hydroxylase is assigned to the CYP27 \'A\' subfamily and 25-hydroxy-vitamin D~3~1 α-hydroxylase to the \'B\' subfamily. If another enzyme were to be discovered that shared \> 55 per cent identity with sterol 27-hydroxylase, it would be named CYP27A2. Another enzyme was discovered that shared \< 55 per cent but \> 40 per cent identity with sterol 27-hydroxylase, as well as with the 25-hydroxy-vitamin D~3~1 α-hydroxylase, and therefore it was named CYP27C1. The development and application of this pleasingly logical system of nomenclature to the genes of many animals, plants and bacteria <http://drnelson.utmem.edu/CytochromeP450.html> has eliminated the confusion that often has plagued the naming of gene families and superfamilies. Subsequently, this \'divergent evolution\' nomenclature system has been adopted for the *ABC*gene family, among many others. The human subfamilies and members within each subfamily can be seen (Figure [1](#F1){ref-type="fig"}) to have diverged over evolutionary time. The nomenclature for both the human *ABC*gene family and the *CYP*gene superfamily has been approved by the HUGO Gene Nomenclature Committee (HGNC; <http://www.genenames.org>).

Conclusions
===========

The family of ABC pumps, along with the super-family of SLC proteins summarised in the last issue of *Human Genomics*\[[@B2]\], are among the most important large classes of transporters that move inorganic ions, metals, peptides, steroids, nucleosides, sugars and many other small molecules across the cell\'s surface membrane, as well as organelle membranes within cells. The *ABC*gene family of transporters comprises 49 and 52 genes (in eight subfamilies) in the human and mouse genomes, respectively; the nomenclature of these genes is based strictly on divergent evolution. The *SLC*gene superfamily is composed of 362 genes in 55 families in the human genome; the nomenclature of those genes is based largely on biochemical function, rather than divergent evolution from a common ancestor \[[@B2]\].

The ABC transporters are critically important in innumerable physiological functions, underscored by the fact that defects in more than a dozen of these genes have been associated with severe inherited disorders of metabolism \-- cystic fibrosis being among the most prominent diseases, caused by mutations in the *CFTR*gene. The ABC transporters are also of great clinical importance in the transport of cancer chemotherapeutics, numerous other drugs and metabolites, and many chemicals present in foodstuffs. ABC transporters are therefore likely targets for drug therapy. A large number of new studies focused on the ABC transporter genes are anticipated.

Acknowledgements
================

We thank our colleagues, especially Lei He, for valuable discussions and a careful reading of this manuscript. The writing of this paper was funded, in part, by NIH grants R01 EY11490 (V.V.) and P30 ES06096 (D.W.N.).
